Purpose: To implement an integrated reconstruction pipeline including a graphics processing unit (GPU)-based convolutional neural network (CNN) architecture and test whether it reconstructs four-dimensional non-Cartesian, non-contrast material-enhanced MR angiographic k-space data faster than a central processing unit (CPU)-based compressed sensing (CS) reconstruction pipeline, without significant losses in data fidelity, summed visual score (SVS), or arterial vessel-diameter measurements.
Materials and methods: Raw k-space data of 24 patients (18 men and six women; mean age, 56.8 years ± 11.8 [standard deviation]) suspected of having thoracic aortic disease were used to evaluate the proposed reconstruction pipeline derived from an open-source three-dimensional CNN. For training, 4800 zero-filled images and the corresponding CS-reconstructed images from 10 patients were used as input-output pairs. For testing, 6720 zero-filled images from 14 different patients were used as inputs to a trained CNN. Metrics for evaluating the agreement between the CNN and CS images included reconstruction times, structural similarity index (SSIM) and normalized root-mean-square error (NRMSE), SVS (3 = nondiagnostic, 9 = clinically acceptable, 15 = excellent), and vessel diameters.
Results: The mean reconstruction time was 65 times and 69 times shorter for the CPU-based and GPU-based CNN pipelines (216.6 seconds ± 40.5 and 204.9 seconds ± 40.5), respectively, than for CS (14 152.3 seconds ± 1708.6) (P < .001). Compared with CS as practical ground truth, CNNs produced high data fidelity (SSIM = 0.94 ± 0.02, NRMSE = 2.8% ± 0.4) and not significantly different (P = .25) SVS and aortic diameters, except at one out of seven locations, where the percentage difference was only 3% (ie, clinically irrelevant).
Conclusion: The proposed integrated reconstruction pipeline including a CNN architecture is capable of rapidly reconstructing time-resolved volumetric cardiovascular MRI k-space data, without a significant loss in data quality, thereby supporting clinical translation of said non-contrast-enhanced MR angiograms. Supplemental material is available for this article. © RSNA, 2020.
2020 by the Radiological Society of North America, Inc.